1-20 of 56
Richard M. Bergenstal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Jennifer L. Sherr, Lutz Heinemann, G. Alexander Fleming, Richard M. Bergenstal, Daniela Bruttomesso, Hélène Hanaire, Reinhard W. Holl, John R. Petrie, Anne L. Peters, Mark Evans
Journal: Diabetes Care
Diabetes Care 2022;45(12):3058–3074
DOI: https://doi.org/10.2337/dci22-0018
Published: 06 October 2022
View article titled, Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association
Open the PDF for Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association in another window
Journal Articles

Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729–2737

Ryan Bailey, Peter Calhoun, Roy W. Beck, Richard M. Bergenstal, Grazia Aleppo
Journal: Diabetes Care
Diabetes Care 2022;45(4):e85–e86
DOI: https://doi.org/10.2337/dci22-0006
Published: 29 March 2022
View article titled, Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729–2737
Open the PDF for Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729–2737 in another window
Journal Articles

Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study

Rose A. Gubitosi-Klug, Barbara H. Braffett, Ionut Bebu, Mary L. Johnson, Kaleigh Farrell, David Kenny, Victoria R. Trapani, Lynne Meadema-Mayer, Elsayed Z. Soliman, Rodica Pop-Busui, John M. Lachin, Richard M. Bergenstal, William V. Tamborlane
Journal: Diabetes Care
Diabetes Care 2022;45(3):659–665
DOI: https://doi.org/10.2337/dc21-0629
Published: 25 January 2022
View article titled, Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study
Open the PDF for Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study in another window
Journal Articles

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin

Grazia Aleppo, Roy W. Beck, Ryan Bailey, Katrina J. Ruedy, Peter Calhoun, Anne L. Peters, Rodica Pop-Busui, Athena Philis-Tsimikas, Shichun Bao, Guillermo Umpierrez, Georgia Davis, Davida Kruger, Anuj Bhargava, Laura Young, John B. Buse, Janet B. McGill, Thomas Martens, Quang T. Nguyen, Ian Orozco, William Biggs, K. Jean Lucas, William H. Polonsky, David Price, Richard M. Bergenstal, MOBILE Study Group, Thomas Martens, Anders Carlson, Richard M. Bergenstal, Sharon Chambers, Shoua Yang, Laura Young, John Buse, M. Sue Kirkman, Alexander Kass, Rachael Fraser, Davida Kruger, Terra Cushman, Georgia Davis, Clementina Ramos, Guillermo Umpierrez, Anne L. Peters, Maria Magar, Martha Walker, Sara Serafin-Dokhan, Janet B. McGill, Maamoun Salam, Stacy Hurst, Mary Jane Clifton, Grazia Aleppo, Jelena Kravarusic, Anupam Bansal, Candice Fulkerson, Rodica Pop-Busui, Lynn Ang, Caroline Richardson, Kara Mizokami-Stout, Jake Reiss, Virginia Leone, Anuj Bhargava, Kirstie Stifel, Athena Philis-Tsimikas, George Dailey, Amy Change, James McCallum, Maria Isabel Garcia, Shichun Bao, Dianne Davis, Cynthia Lovell, Connie Root, William Biggs, Freida Toler, Lori Wilhelm, Robin Eifert, Lorena Murguia, Becky Cota, Quang T. Nguyen, Loida Nguyen, Randie Lipski, Ian Orozco, Mary Katherine Lawrence, Adelle Fournier, Matthew Carter, K. Jean Lucas, Stephanie Hoover, Roy W. Beck, Katrina J. Ruedy, Peter Calhoun, Ryan Bailey, Nathan Cohen, Thomas Mouse, Jessica Rusnak, Tiffany Campos, David Price, Nelly Njeru, Tom Arant, Stayce E. Beck, Andrew Balo
Journal: Diabetes Care
Diabetes Care 2021;44(12):2729–2737
DOI: https://doi.org/10.2337/dc21-1304
Published: 29 September 2021
View article titled, The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Open the PDF for The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin in another window
Journal Articles

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Sue A. Brown, Gregory P. Forlenza, Bruce W. Bode, Jordan E. Pinsker, Carol J. Levy, Amy B. Criego, David W. Hansen, Irl B. Hirsch, Anders L. Carlson, Richard M. Bergenstal, Jennifer L. Sherr, Sanjeev N. Mehta, Lori M. Laffel, Viral N. Shah, Anuj Bhargava, Ruth S. Weinstock, Sarah A. MacLeish, Daniel J. DeSalvo, Thomas C. Jones, Grazia Aleppo, Bruce A. Buckingham, Trang T. Ly, Omnipod 5 Research Group, Sue A. Brown, Mary Voelmle, Emma Emory, Gregory P. Forlenza, R. Paul Wadwa, Robert Slover, Erin Cobry, Laurel H. Messer, Cari Berget, Susan McCoy, Viral N. Shah, Halis K. Akturk, Nicole Schneider, Hal Joseph, Prakriti Joshee, Christie Beatson, Bruce W. Bode, Brooke Narron, Tricia Lopez, Jordan E. Pinsker, Mei Mei Church, Kristin Castorino, Molly Piper, Jimena Perez, Carol J. Levy, David W. Lam, Camilla Levister, Grenye O’Malley, Selassie Ogyaadu, Dushyanthy Arasaratnam, Mitchell Plesser, Emily Nosova, Suzan Bzdick, David W. Hansen, Sheri L. Stone, Ruth S. Weinstock, Irl B. Hirsch, Subbulaxmi Trikudanathan, Nancy Sanborn, Dori Khakpour, Anders L. Carlson, Amy B. Criego, Richard M. Bergenstal, Thomas Martens, Aimee Grieme, Jamie Hyatt, Alina Punel, Diane Whipple, Jennifer L. Sherr, Michelle Van Name, Michelle Brei, Melinda Zgorski, Amy Steffen, Lori Carria, Sanjeev N. Mehta, Lori M. Laffel, Lindsay Roethke, Margaret Fisher, Rebecca Ortiz La Banca, Lisa Volkening, Louise Ambler-Osborn, Christine Turcotte, Emily F. Freiner, Anuj Bhargava, Lisa Borg, Sarah A. MacLeish, Jamie R. Wood, Beth A. Kaminski, Terri L. Casey, Wendy Campbell, Daniel J. DeSalvo, Siripoom McKay, Mary Kylie DeLaO, Carolina Villegas, Thomas C. Jones, Barry Russel Johns, Ashwini Gore, Leslie Harvill, Kayla Merritt, Jennifer Stanfield, Jennifer Sheldon, Lisa Hichkad, Erica Burnett, Alicia Castelot, Lindsay Bounds, Kaitlyn Preston, Rebecca Goldfaden, Grazia Aleppo, Jelena Kravarusic, Anupam Bansal, Bruce A. Buckingham, Laya Ekhlaspour, Ryan Kingman, Kaisa Kivilaid, Krista Kleve, Trang T. Ly, Bonnie Dumais, Todd Vienneau, Lauren M. Huyett, Joon Bok Lee, Jason O’Connor, Eric Benjamin
Journal: Diabetes Care
Diabetes Care 2021;44(7):1630–1640
DOI: https://doi.org/10.2337/dc21-0172
Published: 20 July 2021
View article titled, Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Open the PDF for Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes in another window
Journal Articles

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial

Harpreet S. Bajaj, Richard M. Bergenstal, Andreas Christoffersen, Melanie J. Davies, Amoolya Gowda, Joakim Isendahl, Ildiko Lingvay, Peter A. Senior, Robert J. Silver, Roberto Trevisan, Julio Rosenstock
Journal: Diabetes Care
Diabetes Care 2021;44(7):1586–1594
DOI: https://doi.org/10.2337/dc20-2877
Published: 19 March 2021
View article titled, Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
Open the PDF for Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial in another window
Journal Articles

Continuous Glucose Monitoring–Derived Data Report—Simply a Better Management Tool

Tadej Battelino, Richard M. Bergenstal
Journal: Diabetes Care
Diabetes Care 2020;43(10):2327–2329
DOI: https://doi.org/10.2337/dci20-0032
Published: 11 September 2020
View article titled, Continuous Glucose Monitoring–Derived Data Report—Simply a Better Management Tool
Open the PDF for Continuous Glucose Monitoring–Derived Data Report—Simply a Better Management Tool in another window
Journal Articles

Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes

Lalantha Leelarathna, Hood Thabit, Malgorzata E. Willinska, Lia Bally, Julia K. Mader, Sabine Arnolds, Carsten Benesch, Thomas R. Pieber, Viral N. Shah, Anders L. Carlson, Richard M. Bergenstal, Mark L. Evans, Roman Hovorka
Journal: Diabetes Care
Diabetes Care 2020;43(3):e38–e39
DOI: https://doi.org/10.2337/dc19-2041
Published: 16 January 2020
View article titled, Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes
Open the PDF for Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes in another window
Journal Articles

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

G. Alexander Fleming, John R. Petrie, Richard M. Bergenstal, Reinhard W. Holl, Anne L. Peters, Lutz Heinemann
Journal: Diabetes Care
Diabetes Care 2020;43(1):250–260
DOI: https://doi.org/10.2337/dci19-0062
Published: 12 December 2019
View article titled, Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Open the PDF for Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group in another window
Journal Articles

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

Tadej Battelino, Thomas Danne, Richard M. Bergenstal, Stephanie A. Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A. Buckingham, William T. Cefalu, Kelly L. Close, Claudio Cobelli, Eyal Dassau, J. Hans DeVries, Kim C. Donaghue, Klemen Dovc, Francis J. Doyle, III, Satish Garg, George Grunberger, Simon Heller, Lutz Heinemann, Irl B. Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris Kovatchev, Aaron Kowalski, Lori Laffel, Brian Levine, Alexander Mayorov, Chantal Mathieu, Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Eric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip
Journal: Diabetes Care
Diabetes Care 2019;42(8):1593–1603
DOI: https://doi.org/10.2337/dci19-0028
Published: 08 June 2019
View article titled, Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Open the PDF for Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range in another window
Includes: Supplementary data
Journal Articles

Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery

Klemen Dovc, Charlotte Boughton, Martin Tauschmann, Hood Thabit, Lia Bally, Janet M. Allen, Carlo L. Acerini, Sabine Arnolds, Carine de Beaufort, Richard M. Bergenstal, Fiona Campbell, Amy Criego, David B. Dunger, Daniella Elleri, Mark L. Evans, Elke Fröhlich-Reiterer, Sabine Hofer, Thomas Kapellen, Lalantha Leelarathna, Thomas R. Pieber, Birgit Rami-Merhar, Viral N. Shah, Judy Sibayan, Malgorzata E. Wilinska, Roman Hovorka, APCam11, AP@Home, and KidsAP Consortia, Klemen Dovc, Martin Tauschmann, Charlotte Boughton, Gianluca Musolino, Hood Thabit, Lia Bally, Sonja Slegtenhorst, Janet M. Allen, Malgorzata E. Wilinska, Yue Ruan, Josephine Hayes, Nicole Barber, Jane Curtis, Carlo L. Acerini, David B. Dunger, Mark L. Evans, Roman Hovorka, Lalantha Leelarathna, Hood Thabit, Angel Shaju, Stefanie Yau, Linda James, Karthirani Balakrishnan, Denise Donahue, Womba Mubita, Jane Exall, James Yong, Rachel Forshaw, Rebecca Pad, Stephanie Heath, Emily Metcalfe, Fiona Campbell, Judy Sibayan, Craig Kollman, Peiyao Cheng, Roy W. Beck, John Lum, Sarah Borgman, Viki Huegel, Sydnee Bradshaw, Amanda Hellman, Nanadan Patibandla, Chris McCarthy, Carlos Murphy, Brian Bugielski, Barvan Alvarado, Daniella Elleri, Morag McDonald, Louise Bath, Harriet Miles, Debbie Miller, Emily Collett, Julie Baggott, Key Riding, Jane Thomson, Richard M. Bergenstal, Amy Criego, Anders B. Carlson, Thomas Martens, Shannon Beasley, M. Madden, Beth Olson, Jamie Hyatt, Charlotte Ashanti, Vera Mikityuk, LeeAnn Thomas, Wanda Konerza, Viral N. Shah, Hal Joseph, Christie R. Beatson, Jamie K. Demmitt, Prakriti Joshee, Dawn White, Harald Kojzar, Julia K. Mader, Elisabeth Suppan, Thomas R. Pieber, Erike E. Fröhlich-Reiterer, Martin Ellmerer, Manuel Holzer, Dominique Schaeffer, Muriel Fichelle, Ulrike Schierloh, Carine de Beaufort, Alena G. Thiele, Heike Bartelt, Thomas M. Kapellen, Daniela Abt, Dagmar Meraner, Elisabeth Binder, Elisabeth Steichen, Lukas Hackl, Sabine Hofer, Birgit Rami Merhar, Maria Fritsch, Katrin Nagl, Sonja Katzenbeisser-Pawlik, Martin Tauschmann, Sabine Arnolds, Carsten Benesch, Sibylle Dellweg, Martina Haase, Lutz Heinemann, Kirstin Kuschma, Maren Luebkert, Elke Przetak, Krisztina Schmitz-Grozs
Journal: Diabetes Care
Diabetes Care 2019;42(7):1344–1347
DOI: https://doi.org/10.2337/dc18-2625
Published: 21 May 2019
View article titled, Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery
Open the PDF for Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery in another window
Includes: Supplementary data
Journal Articles

Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data

Lalantha Leelarathna, Roy W. Beck, Richard M. Bergenstal, Hood Thabit, Roman Hovorka
Journal: Diabetes Care
Diabetes Care 2019;42(4):e60–e61
DOI: https://doi.org/10.2337/dc18-2479
Published: 06 February 2019
View article titled, Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data
Open the PDF for Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data in another window
Journal Articles

Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280

Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, George Grunberger, David B. Sacks, Aaron Kowalski, Adam S. Brown, Lutz Heinemann, Grazia Aleppo, Donna B. Ryan, Tonya D. Riddlesworth, William T. Cefalu
Journal: Diabetes Care
Diabetes Care 2019;42(2):e29–e30
DOI: https://doi.org/10.2337/dci18-0061
Published: 17 December 2018
View article titled, Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280
Open the PDF for Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280 in another window
Journal Articles

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

Roy W. Beck, Richard M. Bergenstal, Tonya D. Riddlesworth, Craig Kollman, Zhaomian Li, Adam S. Brown, Kelly L. Close
Journal: Diabetes Care
Diabetes Care 2019;42(3):400–405
DOI: https://doi.org/10.2337/dc18-1444
Published: 23 October 2018
View article titled, Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Open the PDF for Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials in another window
Includes: Supplementary data
Journal Articles

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, George Grunberger, David B. Sacks, Aaron Kowalski, Adam S. Brown, Lutz Heinemann, Grazia Aleppo, Donna B. Ryan, Tonya D. Riddlesworth, William T. Cefalu
Journal: Diabetes Care
Diabetes Care 2018;41(11):2275–2280
DOI: https://doi.org/10.2337/dc18-1581
Published: 17 September 2018
View article titled, Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
Open the PDF for Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring in another window
Includes: Supplementary data
Journal Articles

International Consensus on Use of Continuous Glucose Monitoring

Thomas Danne, Revital Nimri, Tadej Battelino, Richard M. Bergenstal, Kelly L. Close, J. Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A. Amiel, Roy Beck, Emanuele Bosi, Bruce Buckingham, Claudio Cobelli, Eyal Dassau, Francis J. Doyle, III, Simon Heller, Roman Hovorka, Weiping Jia, Tim Jones, Olga Kordonouri, Boris Kovatchev, Aaron Kowalski, Lori Laffel, David Maahs, Helen R. Murphy, Kirsten Nørgaard, Christopher G. Parkin, Eric Renard, Banshi Saboo, Mauro Scharf, William V. Tamborlane, Stuart A. Weinzimer, Moshe Phillip
Journal: Diabetes Care
Diabetes Care 2017;40(12):1631–1640
DOI: https://doi.org/10.2337/dc17-1600
Published: 10 November 2017
View article titled, International Consensus on Use of Continuous Glucose Monitoring
Open the PDF for International Consensus on Use of Continuous Glucose Monitoring in another window
Includes: Supplementary data
Journal Articles

Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

John R. Petrie, Anne L. Peters, Richard M. Bergenstal, Reinhard W. Holl, G. Alexander Fleming, Lutz Heinemann
Journal: Diabetes Care
Diabetes Care 2017;40(12):1614–1621
DOI: https://doi.org/10.2337/dci17-0043
Published: 25 October 2017
View article titled, Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: <span class="subtitle">A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group</span>
Open the PDF for Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: <span class="subtitle">A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group</span> in another window
Journal Articles

Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777–783

John M. Lachin, Ionut Bebu, Richard M. Bergenstal, Rodica Pop-Busui, F. John Service, Bernard Zinman, David M. Nathan, for the DCCT/EDIC Research Group
Journal: Diabetes Care
Diabetes Care 2017;40(11):e165–e166
DOI: https://doi.org/10.2337/dci17-0038
Published: 12 October 2017
View article titled, Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777–783
Open the PDF for Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777–783 in another window
Journal Articles

The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading

Roy W. Beck, Crystal G. Connor, Deborah M. Mullen, David M. Wesley, Richard M. Bergenstal
Journal: Diabetes Care
Diabetes Care 2017;40(8):994–999
DOI: https://doi.org/10.2337/dc17-0636
Published: 11 July 2017
View article titled, The Fallacy of Average: How Using HbA<sub>1c</sub> Alone to Assess Glycemic Control Can Be Misleading
Open the PDF for The Fallacy of Average: How Using HbA<sub>1c</sub> Alone to Assess Glycemic Control Can Be Misleading in another window
Journal Articles

Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39: 1972–1980

Vanita R. Aroda, Julio Rosenstock, Carol Wysham, Jeffrey Unger, Diego Bellido, Guillermo González-Gálvez, Akane Takami, Hailing Guo, Elisabeth Niemoeller, Elisabeth Souhami, Richard M. Bergenstal, on behalf of the LixiLan-L Trial Investigators
Journal: Diabetes Care
Diabetes Care 2017;40(6):809
DOI: https://doi.org/10.2337/dc17-er06d
Published: 20 April 2017
View article titled, Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39: 1972–1980
Open the PDF for Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39: 1972–1980 in another window